24 completed, 5 not yet recruiting, 3 unknown, 2 recruiting. 36 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 36 | Completed 24, Not yet recruiting 5, Unknown 3, Recruiting 2, Terminated 2 |
Follow Dermatomycoses: new trials by email Literature Review of Dermatomycoses trials Research Report on Dermatomycoses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Efficacy of Luliconazole and Bifonazole Combined With Itraconazole in Dermatophytosis Itraconazole, Luliconazole Cream 1%, Bifonazole cream 1% - Tinea Corporis, Tinea Cruris | Phase 4 | Not yet recruiting | University of Faisalabad | 182 | 2026-12-01 | 2026-11-12 |
| Comparison of Itraconazole With Itraconazole and Isotretinoin in the Treatment Duration, Safety a n d Cure Rate in Adult Patients of Tinea Corporis/ Cruris-A Randomised Controlled Trail Itraconazole (200 mg), ISOtretinoin 20 MG - Tinea Corporis | Phase 4 | Not yet recruiting | Pak Emirates Military Hospital | 60 | 2026-10-01 | 2026-06-30 |
| Comparison of the Efficacy of Topical Luliconazole 2% Cream vs Topical Ketoconazole 1% Cream in the Treatment of Pityriasis Versicolor. Luliconazole Cream 1%, Topical ketoconazole 2% cream - Pityriasis Versicolor | Phase 4 | Not yet recruiting | PAEC General Hospital, Islamabad | 86 | 2026-02-01 | 2026-01-12 |
| Mycological Efficacy and Safety of Ketoconazole 2% Shampoo With a Seven-Day Versus Three-Day Treatment Duration in Pityriasis Versicolor Ketoconazole 2% Shampoo, Placebo Shampoo - Pityriasis Versicolor | Phase 4 | Not yet recruiting | Fakultas Kedokteran Universitas Indonesia | 76 | 2026-02-01 | 2026-03-13 |
| Oral Fluconazole vs Oral Terbinafine for Tinea Capitis in Children Aged 2-10 Years Fluconazole., Terbinafine., Ketoconazole 2% shampoo - Tinea Capitis | Phase 4 | Completed | Dr. Amara Safdar | 64 | 2025-12-01 | 2026-11-10 |
| Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis Itraconazole (200 mg), Fluconazole 150 mg - Tinea Corporis, Dermatophytosis | Phase 4 | Recruiting | Urooj Fatima | 126 | 2025-11-01 | 2026-01-15 |
| Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor Fluconazole, Itraconazole - Pityriasis Versicolor | Phase 4 | Recruiting | Khyber Teaching Hospital | 106 | 2025-03-01 | 2025-04-10 |
| Efficacy of Tropical Sertaconazole Nitrate 2% Vs Clotrimazole 1% for Tinea Pedis Topical Sertaconazole 2%, Clotrimazole 1% - Tinea Pedis | Phase 4 | Not yet recruiting | Jinnah Postgraduate Medical Centre | 100 | 2025-03-01 | 2025-03-11 |
| Diode Laser and Photodynamic Therapy Vs. Ciclopirox. Diode laser combined with photodynamic-red laser therapy by RapidoPodia Laser Diodo®, Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer - Onychomycosis | Phase 4 | Unknown | Universidad Complutense de Madrid | 26 | 2023-09-01 | 2023-05-10 |
| 8% Sulphur-Aloe Vera Soap as an Adjuvant Treatment for Pityriasis Versicolor 8% sulphur and A. vera soap - Pityriasis Versicolor | Phase 4 | Completed | Universitas Padjadjaran | 42 | 2023-08-25 | 2024-03-26 |
| Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis amphotericin B in 30% DMSO, 30% DMSO - Fungal Infection, Onychomycosis | Phase 4 | Completed | Mahidol University | 19 | 2019-01-15 | 2021-09-28 |
| The Comparative Assessment of Mycological Efficacy, Safety, Recurrence, and Cost-effectiveness of Selenium Sulfide 1.8% Shampoo Versus Ketoconazole 2% Shampoo in Pityriasis Versicolor: a Double-blind Randomized Controlled Trial shampoo with different composition - Pityriasis Versicolor | Phase 4 | Completed | Universitas Indonesia | 100 | 2018-09-01 | 2019-07-05 |
| Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis Jublia® - Mild to Moderate Onychomycosis Due to Dermatophyte | Phase 4 | Completed | Dong-A ST Co., Ltd. | 97 | 2017-11-10 | 2021-04-27 |
| Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis Efinaconazole - Onychomycosis | Phase 4 | Completed | Bausch Health Americas, Inc. | 62 | 2016-08-04 | 2021-11-01 |
| Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte Onychomycosis 1,064nm Long-pulsed Nd:YAG, Amorolfine - Non-dermatophyte Onychomycosis | Phase 4 | Completed | Mahidol University | 60 | 2016-08-01 | 2021-09-28 |
| Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis Luliconazole Cream 1%, Vehicle Cream - Tinea Corporis | Phase 4 | Completed | Bausch Health Americas, Inc. | 75 | 2016-02-08 | 2019-11-27 |
| Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1% Loceryl Nail Lacquer, Urea Ointment, Bifonazole Cream - Foot Dermatoses | Phase 4 | Completed | Galderma R&D | 22 | 2016-01-01 | 2021-02-17 |
| Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris Luliconazole Cream 1% - Tinea Pedis, Tinea Cruris | Phase 4 | Completed | Bausch Health Americas, Inc. | 30 | 2015-12-02 | 2019-11-27 |
| An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents Tavaborole 5% Topical Solution - Onychomycosis, Tinea Unguium | Phase 4 | Completed | Pfizer | 55 | 2015-10-22 | 2018-04-17 |
| Study Evaluating the Effect of Jublia on Dermatophytomas Jublia (Efinaconazole 10% Topical Solution) - Onychomycosis, Dermatophytosis | Phase 4 | Completed | University of Alabama at Birmingham | 19 | 2015-09-01 | 2019-12-10 |
Showing 20 of 36. Sign in to see all of them.
Onychomycosis (16) · Tinea (9) · Tinea Versicolor (6) · Tinea Cruris (4) · Tinea Pedis (4) · Foot Dermatoses (3) · Mycoses (3) · Aspergillosis (1) · Blastomycosis (1) · Candidiasis (1) · Cellulitis (1) · Infections (1) · Mycetoma (1) · Nail Diseases (1)
Bacterial Infections and Mycoses (36) · Skin Diseases (36) · Skin Diseases, Infectious (36) · Skin and Connective Tissue Diseases (36) · Infections (35) · Mycoses (33) · Tinea (19) · Nail Diseases (15) · Foot Diseases (7) · Pathological Conditions, Signs and Symptoms (5) · Dermatitis (4) · Foot Dermatoses (4) · Intertrigo (4) · Pruritus (4)
Itraconazole (6) · Ketoconazole (4) · Ciclopirox (3) · Fluconazole (3) · amorolfine (3) · efinaconazole (3) · Amphotericin B (2) · Solutions (2) · Terbinafine (2) · Antifungal Agents (1) · Dimethyl Sulfoxide (1) · Isotretinoin (1) · Keratolytic Agents (1) · Lasers (1) · Omeprazole (1)
Bausch Health Americas, Inc. (3) · Galderma R&D (3) · Mahidol University (3) · Merz North America, Inc. (3) · Bausch & Lomb Incorporated (1) · Boni Elewski, MD (1) · Dong-A ST Co., Ltd. (1) · Dr. Amara Safdar (1) · Fakultas Kedokteran Universitas Indonesia (1) · Ferrer Internacional S.A. (1) · Helsinki University Central Hospital (1) · Janssen Korea, Ltd., Korea (1) · Jinnah Postgraduate Medical Centre (1) · Khyber Teaching Hospital (1) · MB Mazor Ltd. (1)
United States (9) · Dominican Republic (6) · Honduras (5) · Pakistan (5) · Thailand (3) · Iceland (2) · Indonesia (2) · Canada (1) · Finland (1) · France (1) · Germany (1) · India (1) · Israel (1) · Panama (1) · Puerto Rico (1)
Anya Loncaric (3) · Alan Fleischer, MD (2) · Boni E Elewski, MD (2) · Alan B. Fleischer, MD (1) · Avner Shemer, MD (1) · Binu Alexander, MD (1) · Charussri Leeyaphan, MD (1) · Eliza Miranda, MD, PhD (1) · Janne J. Jokinen, MD, PhD (1) · Jose C Moreno, Prof, PhD (1)
PMID 10233295, PMID 10642676, PMID 14723731, PMID 20347657, PMID 21820203, PMID 22236569, PMID 22976905, PMID 23278851, PMID 23416171, PMID 23496375, PMID 24079583, PMID 25013957, PMID 25639524, PMID 26471716, PMID 27799043, PMID 27815659, PMID 30811142, PMID 36103158, PMID 41024682
2008 (1), 2015 (1)